Compare Novo Nordisk A/S (NVO) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Snap Inc — how do they compare? Novo Nordisk A/S trades at $45.75 (market cap $207.85B), while Snap Inc trades at $5.49 (market cap $9.32B). The key difference: Novo Nordisk A/S is far larger — about 22.3× Snap Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| NVO | SNAP | |
|---|---|---|
Market Cap | $207.85B | $9.32B |
Sector | Health | Media |
52-Week High | $63.98 | $9.09 |
52-Week Low | $35.29 | $3.93 |
Enterprise Value | $222.55B | $10.88B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
